Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative analysis of microRNA profiles of rice anthers between cool-sensitive and cool-tolerant cultivars under cool-temperature stress.
Maeda S, Sakazono S, Masuko-Suzuki H, Taguchi M, Yamamura K, Nagano K, Endo T, Saeki K, Osaka M, Nabemoto M, Ito K, Kudo T, Kobayashi M, Kawagishi M, Fujita K, Nanjo H, Shindo T, Yano K, Suzuki G, Suwabe K, Watanabe M. Maeda S, et al. Among authors: fujita k. Genes Genet Syst. 2016 Oct 13;91(2):97-109. doi: 10.1266/ggs.15-00056. Epub 2016 Mar 25. Genes Genet Syst. 2016. PMID: 27021915 Free article.
Galectins and Liver Diseases.
Mimura S, Morishita A, Oura K, Takuma K, Nakahara M, Tadokoro T, Fujita K, Tani J, Kobara H. Mimura S, et al. Among authors: fujita k. Int J Mol Sci. 2025 Jan 18;26(2):790. doi: 10.3390/ijms26020790. Int J Mol Sci. 2025. PMID: 39859504 Review.
Eosinophil is a predictor of severe immune-related adverse events induced by ipilimumab plus nivolumab therapy in patients with renal cell carcinoma: a retrospective multicenter cohort study.
Tasaki Y, Hamamoto S, Yamashita S, Furukawa J, Fujita K, Tomida R, Miyake M, Ito N, Iwamoto H, Mimura Y, Sugiyama Y, Unno R, Okada A, Yasui T, Furukawa-Hibi Y. Tasaki Y, et al. Among authors: fujita k. Front Immunol. 2025 Jan 9;15:1483956. doi: 10.3389/fimmu.2024.1483956. eCollection 2024. Front Immunol. 2025. PMID: 39850887 Free PMC article.
Screening for Predictive Factors of Efficacy of Second-Generation Androgen Receptor Axis-Targeted Agents in Patients With High-Risk Metastatic Hormone-Sensitive Prostate Cancer.
Ueda T, Hayakawa K, Horiguchi G, Murashita J, Shiraishi T, Fujimoto S, Miyashita M, Saito Y, Gabata Y, Sako S, Takahashi H, Fujihara A, Minami T, Yamamoto Y, Okumi M, Hongo F, Okihara K, Fujita K, Ukimura O. Ueda T, et al. Among authors: fujita k. Prostate. 2025 Jan 15:e24855. doi: 10.1002/pros.24855. Online ahead of print. Prostate. 2025. PMID: 39815445
5,229 results